Prevenotics provides an AI-powered diagnostic solution that analyzes endoscopic images in real-time during gastroscopy. Its technology identifies pre-cancerous risks to improve early cancer detection and support prognosis management for stomach cancer prevention.
Funding
Funding not disclosed
Founders
Product
Problem
The identification of pre-cancerous conditions during gastroscopy is critical for effective prognosis management and the prevention of diseases like stomach cancer. Current diagnostic methods may not consistently detect subtle pre-cancerous risks, leading to delayed intervention.
Solution
Prevenotics offers an AI-powered diagnostic solution designed to enhance early cancer detection during gastroscopy procedures. Our technology analyzes endoscopic images in real-time to identify pre-cancerous risks, thereby enabling more effective prognosis management and contributing to stomach cancer prevention. By integrating advanced AI algorithms, Prevenotics aims to improve diagnostic accuracy and support clinicians in making timely treatment decisions. This approach facilitates proactive healthcare strategies focused on preventing the progression of pre-cancerous conditions.
Target Audience
Our primary customers are gastroenterologists and endoscopy centers that perform gastroscopy procedures and seek to improve the early detection of pre-cancerous conditions.
Features
- AI-driven real-time analysis of endoscopic imagery for pre-cancerous lesion detection.
- Proprietary algorithms for identifying subtle pathological indicators during gastroscopy.
- Decision support system to assist clinicians in prognosis management.
- Focus on early risk stratification for stomach cancer prevention.
- Integration capabilities with existing endoscopic equipment.